These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 18946234

  • 1. A double-blind non-inferiority clinical study of montelukast, a cysteinyl leukotriene receptor 1 antagonist, compared with pranlukast in patients with seasonal allergic rhinitis.
    Okubo K, Baba K.
    Allergol Int; 2008 Dec; 57(4):383-90. PubMed ID: 18946234
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast.
    Ratner PH, Howland WC, Arastu R, Philpot EE, Klein KC, Baidoo CA, Faris MA, Rickard KA.
    Ann Allergy Asthma Immunol; 2003 May; 90(5):536-42. PubMed ID: 12775135
    [Abstract] [Full Text] [Related]

  • 4. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.
    van Adelsberg J, Philip G, LaForce CF, Weinstein SF, Menten J, Malice MP, Reiss TF, Montelukast Spring Rhinitis Investigator Group.
    Ann Allergy Asthma Immunol; 2003 Feb; 90(2):214-22. PubMed ID: 12602669
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of fixed-dose loratadine/montelukast in seasonal allergic rhinitis: effects on nasal congestion.
    Prenner B, Anolik R, Danzig M, Yao R.
    Allergy Asthma Proc; 2009 Feb; 30(3):263-9. PubMed ID: 19549427
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
    Nayak AS, Philip G, Lu S, Malice MP, Reiss TF, Montelukast Fall Rhinitis Investigator Group.
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A randomized controlled phase II clinical trial comparing ONO-4053, a novel DP1 antagonist, with a leukotriene receptor antagonist pranlukast in patients with seasonal allergic rhinitis.
    Okubo K, Hashiguchi K, Takeda T, Baba K, Kitagoh H, Miho H, Tomomatsu H, Yamaguchi S, Odani M, Yamamotoya H.
    Allergy; 2017 Oct; 72(10):1565-1575. PubMed ID: 28378369
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
    Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM.
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
    [Abstract] [Full Text] [Related]

  • 11. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
    Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, Reiss TF.
    J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172
    [Abstract] [Full Text] [Related]

  • 12. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring.
    Philip G, Malmstrom K, Hampel FC, Weinstein SF, LaForce CF, Ratner PH, Malice MP, Reiss TF, Montelukast Spring Rhinitis Study Group.
    Clin Exp Allergy; 2002 Jul; 32(7):1020-8. PubMed ID: 12100048
    [Abstract] [Full Text] [Related]

  • 13. A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis.
    Wilson AM, Orr LC, Coutie WJ, Sims EJ, Lipworth BJ.
    Clin Exp Allergy; 2002 Jan; 32(1):126-32. PubMed ID: 12002729
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis.
    Yamamoto H, Yamada T, Sakashita M, Kubo S, Susuki D, Tokunaga T, Ogi K, Terasawa Y, Yamashita S, Kayano Y, Masada M, Kimura Y, Fujieda S.
    Allergy Asthma Proc; 2012 Jan; 33(2):e17-22. PubMed ID: 22525385
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
    Virchow JC, Bachert C.
    Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis.
    Patel P, Philip G, Yang W, Call R, Horak F, LaForce C, Gilles L, Garrett GC, Dass SB, Knorr BA, Reiss TF.
    Ann Allergy Asthma Immunol; 2005 Dec; 95(6):551-7. PubMed ID: 16400895
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.